itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens (vol 66, 103288, 2021)

被引:0
|
作者
Liesenborghs, Laurens [1 ,2 ]
Spriet, Isabel [3 ,4 ]
Jochmans, Dirk [1 ]
Belmans, Ann [5 ,6 ]
Gyselinck, Iwein [7 ,8 ]
Teuwen, Laure-Anne [9 ]
ter Horst, Sebastiaan [1 ]
Dreesen, Erwin [10 ]
Geukens, Tatjana [11 ]
Engelen, Matthias M. [12 ,13 ]
Landeloos, Ewout [14 ]
Geldhof, Vincent [9 ]
Ceunen, Helga [15 ,16 ]
Debaveye, Barbara [12 ,13 ]
Vandenberk, Bert [12 ,13 ]
Van der Linden, Lorenz [3 ,4 ]
Jacobs, Sofie [1 ]
Langendries, Lana [1 ]
Boudewijns, Robbert [1 ]
Do, Thuc Nguyen Dan [1 ]
Chiu, Winston [1 ]
Wang, Xinyu [1 ]
Zhang, Xin [1 ]
Weynand, Birgit [17 ]
Vanassche, Thomas [12 ,13 ]
Devos, Timothy [18 ,19 ]
Meyfroidt, Geert [13 ,20 ]
Janssens, Wim [7 ,8 ]
Vos, Robin [7 ,8 ]
Vermeersch, Pieter [21 ,22 ]
Wauters, Joost [16 ,23 ]
Verbeke, Geert [5 ,6 ]
De Munter, Paul [15 ,16 ]
Kaptein, Suzanne J. F. [1 ]
Rocha-Pereira, Joana [1 ]
Delang, Leen [1 ]
Van Wijngaerden, Eric [15 ,16 ]
Neyts, Johan [1 ]
Verhamme, Peter [12 ,13 ]
机构
[1] Katholieke Univ Leuven, Lab Virol & Chemotherapy, Dept Microbiol Immunol & Transplantat, Rega Inst Med Res, Leuven, Belgium
[2] Inst Trop Med, Outbreak Res Team, Dept Clin Sci, Antwerp, Belgium
[3] Katholieke Univ Leuven, Pharm Dept Univ Hosp Leuven, Leuven, Belgium
[4] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium
[5] KU Leuven Univ Leuven, Leuven, Belgium
[6] Univ Hasselt, I BioStat, Leuven, Belgium
[7] Katholieke Univ Leuven, Dept Resp Dis, UZ Leuven, Leuven, Belgium
[8] Katholieke Univ Leuven, CHROMETA, Res Grp BREATHE, Leuven, Belgium
[9] Katholieke Univ Leuven, Lab Angiogenesis & Vasc Metab, Ctr Canc Biol, VIB,Dept Oncol,Leuven Canc Inst, Leuven, Belgium
[10] Katholieke Univ Leuven, Clin Pharmacol & Pharmacotherapy Unit, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium
[11] Katholieke Univ Leuven, Dept Oncol, Lab Translat Breast Canc Res, Leuven, Belgium
[12] UZ, Dept Cardiovasc Sci, Leuven, Belgium
[13] Katholieke Univ Leuven, Leuven, Belgium
[14] VIB KU Leuven, Dept Oncol, Lab Mol Canc Biol, Leuven, Belgium
[15] Katholieke Univ Leuven, Dept Gen Internal Med, UZ Leuven, Leuven, Belgium
[16] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium
[17] Katholieke Univ Leuven, Translat Cell & Tissue Res, Dept Imaging & Pathol, Leuven, Belgium
[18] Katholieke Univ Leuven, Dept Hematol, UZ Leuven, Leuven, Belgium
[19] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Lab Mol Immunol, Rega Inst, Leuven, Belgium
[20] UZ, Dept & Lab Intens Care Med, Leuven, Belgium
[21] Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium
[22] Katholieke Univ Leuven, Dept Clin Lab Med, Leuven, Belgium
[23] Katholieke Univ Leuven, Med Intens Care Unit, Leuven, Belgium
来源
EBIOMEDICINE | 2021年 / 69卷
基金
欧盟地平线“2020”;
关键词
D O I
10.1016/j.ebiom.2021.103454
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] 2-deoxy-D-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial
    Bhatt, Anant Narayan
    Shenoy, Srinivas
    Munjal, Sagar
    Chinnadurai, Vijayakumar
    Agarwal, Apurva
    Kumar, A. Vinoth
    Shanavas, A.
    Kanwar, Ratnesh
    Chandna, Sudhir
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [42] 2-deoxy-d-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial
    Anant Narayan Bhatt
    Srinivas Shenoy
    Sagar Munjal
    Vijayakumar Chinnadurai
    Apurva Agarwal
    A. Vinoth Kumar
    A. Shanavas
    Ratnesh Kanwar
    Sudhir Chandna
    BMC Infectious Diseases, 22
  • [43] Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia A Randomized Clinical Trial
    Collins, Sean P.
    Shotwell, Matthew S.
    Strich, Jeffrey R.
    Gibbs, Kevin W.
    de Wit, Marjolein
    Files, D. Clark
    Harkins, Michelle
    Hudock, Kris
    Merck, Lisa H.
    Moskowitz, Ari
    Apodaca, Krystle D.
    Barksdale, Aaron
    Safdar, Basmah
    Javaheri, Ali
    Sturek, Jeffrey M.
    Schrager, Harry
    Iovine, Nicole M.
    Tiffany, Brian
    Douglas, Ivor
    Levitt, Joseph
    Ginde, Adit A.
    Hager, David N.
    Shapiro, Nathan
    Duggal, Abhijit
    Khan, Akram
    Lanspa, Michael
    Chen, Peter
    Gentile, Nina
    Harris, Estelle
    Gong, Michelle
    Sellers, Subhashini
    Goodwin, Andrew J.
    Tidswell, Mark A.
    Filbin, Michael
    Desai, Neeraj
    Gutierrez, Felix
    Estrada, Vicente
    Burgos, Joaquin
    Boyles, Tom
    Pano-Pardo, Jose R.
    Hussen, Nazreen
    Rosenberg, Yves
    Troendle, James
    Bernard, Gordon R.
    Bistran-Hall, Amanda J.
    Walsh, Kelly
    Casey, Jonathan D.
    Declercq, Josh
    Joly, Meghan Morrison
    Pulley, Jill
    JAMA NETWORK OPEN, 2024, 7 (12)
  • [44] Financial Incentives for COVID-19 Vaccination A Cluster Randomized Clinical Trial
    Ternovski, John
    Jilke, Sebastian
    Keppeler, Florian
    Vogel, Dominik
    JAMA NETWORK OPEN, 2025, 8 (02)
  • [45] SUBPHENOTYPES IN COVID-19 ARDS: SECONDARY ANALYSIS OF A RANDOMIZED CLINICAL TRIAL
    Kast, Rachel
    Bulgarelli, Lucas
    Van Ark, Emily
    Osborn, Jeff
    Rey, Diego
    Siuba, Matthew
    Duggal, Abhijit
    Tomazini, Bruno
    Bueno, Flavia
    Biasi, Alexandre
    Sampaio, Camila
    Olivato, Guilherme
    Pereira, Adriano
    Dal-Pizzol, Felipe
    Azevedo, Luciano
    Neto, Ary Serpa
    Deliberato, Rodrigo
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 126 - 126
  • [46] Thalidomide for the treatment of COVID-19 pneumonia: A randomized controlled clinical trial
    Amra, Babak
    Ashrafi, Farzaneh
    Torki, Mehdi
    Hashemi, Marzieh
    Shirzadi, Mohamad
    Soltaninejad, Forogh
    Sadeghi, Somayeh
    Salmasi, Mehrzad
    Sami, Ramin
    Darakhshandeh, Ali
    Nasirian, Maryam
    Pourajam, Samaneh
    ADVANCED BIOMEDICAL RESEARCH, 2023, 12 (01): : 14
  • [47] Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial
    Rojas-Serrano, Jorge
    Portillo-Vasquez, Angelica Margarita
    Thirion-Romero, Ireri
    Vazquez-Perez, Joel
    Mejia-Nepomuceno, Fidencio
    Ramirez-Venegas, Alejandra
    Perez-Kawabe, Karla Midori
    Perez-Padilla, Rogelio
    PLOS ONE, 2022, 17 (02):
  • [48] Impact of COVID-19 on a Pragmatic, Cluster Randomized Clinical Trial for Fibromyalgia
    Bayman, Emine O.
    Dailey, Dana
    Ecklund, Dixie
    Johnson, Elizabeth M.
    Vance, Carol G. T.
    Zimmerman, Bridget
    Costigan, Michele
    Chimenti, Ruth
    Spencer, Maggie
    Post, Andrew
    Huff, Trevis
    Koepp, Maxine
    Archer, Kristin R.
    Peters, Rick
    Nye, George
    Franck, Carla
    Neill-Hudson, Tina
    Crofford, Leslie
    Sluka, Kathleen
    JOURNAL OF PAIN, 2021, 22 (05): : 586 - 586
  • [49] Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial
    Duarte, M.
    Pelorosso, F.
    Nicolosi, L. N.
    Salgado, V.
    Vetulli, H. M.
    Arquieri, A.
    Azzato, F.
    Coyle, J.
    Davolos, I.
    Fernandez Criado, I.
    Gregori, R.
    Rubio, M. C.
    Sarquis, S. M.
    Whalmann, F.
    Rothlin, R. P.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2965 - 2965
  • [50] Varenicline for smoking reduction in smokers not yet ready to quit: A double-blind, proof-of-concept randomized clinical trial
    Steinberg, Marc L.
    Lu, Shou-En
    Williams, Jill M.
    ADDICTIVE BEHAVIORS, 2018, 84 : 20 - 26